Squadron Capital Management LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

Filing Manager
Squadron Capital Management LLC
Reporting Manager
Squadron Master Fund LP
Security
Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share
Symbol
KTTA
Shares outstanding
23,532,818 shares
Disclosed Ownership
2,329,749 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 11:36:30 UTC
Date of event
31 Dec 2025
Previous filing
05 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Squadron Capital Management LLC disclosed 9.9% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 31 Dec 2025."

Quick Takeaways

  • Squadron Capital Management LLC filed SCHEDULE 13G/A for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
  • Disclosed ownership: 9.9%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 05 Dec 2025.
  • Current filing was accepted on 17 Feb 2026, 11:36.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Squadron Master Fund LP 9.9% 2,329,749 0 2,329,749 /s/ Matthew Sesterhenn Partner, Squadron Partners LLC, its General Partner
Squadron Capital Management LLC 9.9% 2,329,749 0 2,329,749 /s/ Matthew Sesterhenn Partner
Matthew Sesterhenn 9.9% 2,329,749 0 2,329,749 /s/ Matthew Sesterhenn Matthew Sesterhenn
William Blank 9.9% 2,329,749 0 2,329,749 /s/ William Blank William Blank

Sponsored